| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-07 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |